Intended for healthcare professionals


Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial

BMJ 2006; 332 doi: (Published 19 January 2006) Cite this as: BMJ 2006;332:151

The main text and the summary box in this paper by Christian M Jespersen and colleagues (BMJ 2006;332:22-4, 7 Jan) refer to the patients in the trial being followed for up to three years. The authors have clarified that the mean follow-up was 960 (range 900-1070) days.


View Abstract